Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preliminary Study of Pharmacokinetics of Ginkgolides Meglumine Injection.

NCT02046031 is registered in ClinicalTrials.gov with Jiangsu Kanion Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT02046031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02046031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preliminary Study of Pharmacokinetics of Ginkgolides Meglumine Injection.
Lead sponsor
Jiangsu Kanion Pharmaceutical Co., Ltd
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2014
Completion date
June 30, 2014
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke